Innoviva (INVA) Equity Average (2011 - 2026)

Innoviva (INVA) reported Equity Average of $1.3 billion for Q1 2026, up 87.92% on a YoY basis from $669.0 million in Q1 2025, and up 15.2% quarter-over-quarter from $1.1 billion in Q4 2025.

Innoviva (INVA) Equity Average (2011 - 2026) Analysis & Trends

Innoviva has reported Equity Average for 16 years, with the latest figure at $1.3 billion in Q1 2026.

  • For the quarter ending Q1 2026, Equity Average rose 87.92% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 87.92% YoY), and the FY2025 full-year result was $1.1 billion, up 60.53% from the prior year.
  • Equity Average for Q1 2026 stood at $1.3 billion, up from $1.1 billion in the prior quarter.
  • The five-year high for Equity Average was $1.3 billion in Q1 2026, with the low at $539.1 million in Q1 2022.
  • Historically, Equity Average has averaged $703.0 million across 5 years, with a median of $667.0 million in 2024.
  • Annual changes were most pronounced in 2022 — Equity Average declined 17.35% — and 2026, when it jumped 87.92%.
  • Innoviva's Equity Average stood at $603.6 million in 2022, then grew by 7.89% to $651.2 million in 2023, then increased by 4.4% to $679.9 million in 2024, then surged by 60.53% to $1.1 billion in 2025, then climbed by 15.2% to $1.3 billion in 2026.
  • The last three Equity Average figures came in at $1.3 billion (Q1 2026), $1.1 billion (Q4 2025), and $862.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 3.50 Bn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 783.14 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 3.76 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.01 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 21.35 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 19.01 Bn
9 Abivax 90.15 Bn 90.15 Bn - 516.41 Mn
10 Innoviva 1.69 Bn 1.08 Bn 75.83 Mn 1.26 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.26 Bn
Dec 31, 2025 1.09 Bn
Sep 30, 2025 862.39 Mn
Jun 30, 2025 680.86 Mn
Mar 31, 2025 669.03 Mn
Dec 31, 2024 679.85 Mn
Sep 30, 2024 667.03 Mn
Jun 30, 2024 684.60 Mn
Mar 31, 2024 689.32 Mn
Dec 31, 2023 651.22 Mn
Sep 30, 2023 591.29 Mn
Jun 30, 2023 558.29 Mn
Mar 31, 2023 563.64 Mn
Dec 31, 2022 603.58 Mn
Sep 30, 2022 603.42 Mn
Jun 30, 2022 558.84 Mn
Mar 31, 2022 539.08 Mn
Dec 31, 2021 508.87 Mn
Sep 30, 2021 442.78 Mn
Jun 30, 2021 545.21 Mn